Barsouk, A., Elghawy, O., Yang, A., Heidlauf, A., Yu, C., Yang, D., Wang, L., Kurian, M., Goel, K., Rushkin, L., Huang, A., Reed-Guy, L. E., Bleiberg, B. A., Sun, L., Singh, A. P., Cohen, R. B., Aggarwal, C., Marmarelis, M. E., Langer, C. J. (2025). Survival after osimertinib dose-reduction, discontinuation in 1L
            <i>EGFR</i>
            -mutated metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8587